Contattaci
Circa la società
MultiplAI enables remote preventative screening and post treatment monitoring of complex diseases like cancer for anyone on earth. MultiplAI provides a universal remote screening test for complex diseases like cancer. We use a liquid biopsy of whole blood based on RNA sequencing and AI to detect virtually any kind of cancer. It can be used in continuous testing both for preventative screening and post-treatment monitoring. Given that it requires only a simple blood sample, it can be administered remotely, anywhere, and costs a fraction of existing diagnostic methods.
GB
Sconosciuto
Azienda non verificata
Trasparenza aziendale
- Informazioni sull'azienda non verificate
- Chiedi ai loro clienti per le recensioni
- Non ha risposto alle recensioni negative